Global and United States Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Report & Forecast 2023-2028

Report ID: 1860810 | Published Date: Sep 2024 | No. of Page: 99 | Base Year: 2023 | Rating: 4.9 | Webstory: Check our Web story
1 Study Coverage
    1.1 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022) & (US$ Million) Introduction
    1.2 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size for the Year 2017-2028
        1.2.2 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size for the Year 2017-2028
    1.3 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.3.1 The Market Share of United States Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) in Global, 2017 VS 2022 VS 2028
        1.3.2 The Growth Rate of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.4 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Dynamics
        1.4.1 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Industry Trends
        1.4.2 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Drivers
        1.4.3 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Challenges
        1.4.4 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Restraints
    1.5 Study Objectives
    1.6 Years Considered
2 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) by Type
    2.1 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Segment by Type
        2.1.1 Paracetamol
        2.1.2 Ibuprofen
        2.1.3 Aspirin
        2.1.4 Naproxen
        2.1.5 Others
    2.2 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2017, 2022 & 2028)
    2.3 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2017-2028)
    2.4 United States Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2017, 2022 & 2028)
    2.5 United States Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2017-2028)
3 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) by Application
    3.1 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Segment by Application
        3.1.1 Hospital Pharmacies
        3.1.2 Retail Pharmacies
        3.1.3 Online Pharmacies
    3.2 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2017, 2022 & 2028)
    3.3 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2017-2028)
    3.4 United States Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2017, 2022 & 2028)
    3.5 United States Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2017-2028)
4 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Competitor Landscape by Company
    4.1 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Company
        4.1.1 Top Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Companies Ranked by Revenue (2021)
        4.1.2 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Player (2017-2022)
    4.2 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Concentration Ratio (CR)
        4.2.1 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Companies of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) in 2021
        4.2.3 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Headquarters, Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022) & (US$ Million) Type
        4.3.1 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Headquarters and Area Served
        4.3.2 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Companies Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022) & (US$ Million) Type
        4.3.3 Date of International Companies Enter into Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market
    4.4 Companies Mergers & Acquisitions, Expansion Plans
    4.5 United States Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Company
        4.5.1 Top Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Players (2020, 2021 & 2022)
5 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Region
    5.1 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Region (2017-2028)
        5.2.1 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Region: 2017-2022
        5.2.2 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth 2017-2028
        6.1.2 North America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 U.S.
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
        6.2.12 Philippines
    6.3 Europe
        6.3.1 Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth 2017-2028
        6.3.2 Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth 2017-2028
        6.4.2 Latin America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 UAE
7 Company Profiles
    7.1 Novartis
        7.1.1 Novartis Company Details
        7.1.2 Novartis Business Overview
        7.1.3 Novartis Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
        7.1.4 Novartis Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022)
        7.1.5 Novartis Recent Development
    7.2 Pfizer
        7.2.1 Pfizer Company Details
        7.2.2 Pfizer Business Overview
        7.2.3 Pfizer Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
        7.2.4 Pfizer Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022)
        7.2.5 Pfizer Recent Development
    7.3 Boehringer Ingelheim
        7.3.1 Boehringer Ingelheim Company Details
        7.3.2 Boehringer Ingelheim Business Overview
        7.3.3 Boehringer Ingelheim Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
        7.3.4 Boehringer Ingelheim Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022)
        7.3.5 Boehringer Ingelheim Recent Development
    7.4 Teva Pharmaceutical
        7.4.1 Teva Pharmaceutical Company Details
        7.4.2 Teva Pharmaceutical Business Overview
        7.4.3 Teva Pharmaceutical Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
        7.4.4 Teva Pharmaceutical Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022)
        7.4.5 Teva Pharmaceutical Recent Development
    7.5 Hospira
        7.5.1 Hospira Company Details
        7.5.2 Hospira Business Overview
        7.5.3 Hospira Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
        7.5.4 Hospira Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022)
        7.5.5 Hospira Recent Development
    7.6 Lonza Group
        7.6.1 Lonza Group Company Details
        7.6.2 Lonza Group Business Overview
        7.6.3 Lonza Group Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
        7.6.4 Lonza Group Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022)
        7.6.5 Lonza Group Recent Development
    7.7 Mylan
        7.7.1 Mylan Company Details
        7.7.2 Mylan Business Overview
        7.7.3 Mylan Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
        7.7.4 Mylan Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022)
        7.7.5 Mylan Recent Development
    7.8 Aurobindo Pharma
        7.8.1 Aurobindo Pharma Company Details
        7.8.2 Aurobindo Pharma Business Overview
        7.8.3 Aurobindo Pharma Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
        7.8.4 Aurobindo Pharma Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022)
        7.8.5 Aurobindo Pharma Recent Development
    7.9 Dr. Reddy's Laboratories
        7.9.1 Dr. Reddy's Laboratories Company Details
        7.9.2 Dr. Reddy's Laboratories Business Overview
        7.9.3 Dr. Reddy's Laboratories Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
        7.9.4 Dr. Reddy's Laboratories Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022)
        7.9.5 Dr. Reddy's Laboratories Recent Development
    7.10 Actavis
        7.10.1 Actavis Company Details
        7.10.2 Actavis Business Overview
        7.10.3 Actavis Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
        7.10.4 Actavis Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022)
        7.10.5 Actavis Recent Development
    7.11 Wuxi Apptec
        7.11.1 Wuxi Apptec Company Details
        7.11.2 Wuxi Apptec Business Overview
        7.11.3 Wuxi Apptec Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
        7.11.4 Wuxi Apptec Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022)
        7.11.5 Wuxi Apptec Recent Development
    7.12 Zhejiang NHU
        7.12.1 Zhejiang NHU Company Details
        7.12.2 Zhejiang NHU Business Overview
        7.12.3 Zhejiang NHU Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
        7.12.4 Zhejiang NHU Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022)
        7.12.5 Zhejiang NHU Recent Development
8 Research Findings and Conclusion
9 Appendix
    9.1 Research Methodology
        9.1.1 Methodology/Research Approach
        9.1.2 Data Source
    9.2 Author Details
    9.3 Disclaimer
List of Tables
    Table 1. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
    Table 2. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Trends
    Table 3. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Drivers
    Table 4. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Challenges
    Table 5. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Restraints
    Table 6. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Companies in Global Market, Ranking by Revenue (2021)
    Table 11. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Player, (US$ Million), 2017-2022
    Table 12. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Share by Player, 2017-2022
    Table 13. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) as of 2021)
    Table 15. Top Players of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) in Global Market, Headquarters and Area Served
    Table 16. Companies Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022) & (US$ Million) Type
    Table 17. Date of International Companies Enter into Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Top Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Players in United States Market, Ranking by Revenue (2021)
    Table 20. United States Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 21. United States Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Share by Players, 2020, 2021 & 2022
    Table 22. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 23. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Region (2017-2022) & (US$ Million)
    Table 24. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Forecast by Region (2023-2028) & (US$ Million)
    Table 25. North America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales in Value by Country (2017-2028) & (US$ Million)
    Table 26. Asia Pacific Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales in Value by Region (2017-2028) & (US$ Million)
    Table 27. Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales in Value by Country (2017-2028) & (US$ Million)
    Table 28. Latin Americaa Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales in Value by Country (2017-2028) & (US$ Million)
    Table 29. Middle East and Africa Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales in Value by Country (2017-2028) & (US$ Million)
    Table 30. Novartis Company Details
    Table 31. Novartis Business Overview
    Table 32. Novartis Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product
    Table 33. Novartis Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022) & (US$ Million)
    Table 34. Novartis Recent Development
    Table 35. Pfizer Company Details
    Table 36. Pfizer Business Overview
    Table 37. Pfizer Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product
    Table 38. Pfizer Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022) & (US$ Million)
    Table 39. Pfizer Recent Development
    Table 40. Boehringer Ingelheim Company Details
    Table 41. Boehringer Ingelheim Business Overview
    Table 42. Boehringer Ingelheim Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product
    Table 43. Boehringer Ingelheim Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022) & (US$ Million)
    Table 44. Boehringer Ingelheim Recent Development
    Table 45. Teva Pharmaceutical Company Details
    Table 46. Teva Pharmaceutical Business Overview
    Table 47. Teva Pharmaceutical Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product
    Table 48. Teva Pharmaceutical Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022) & (US$ Million)
    Table 49. Teva Pharmaceutical Recent Development
    Table 50. Hospira Company Details
    Table 51. Hospira Business Overview
    Table 52. Hospira Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product
    Table 53. Hospira Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022) & (US$ Million)
    Table 54. Hospira Recent Development
    Table 55. Lonza Group Company Details
    Table 56. Lonza Group Business Overview
    Table 57. Lonza Group Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product
    Table 58. Lonza Group Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022) & (US$ Million)
    Table 59. Lonza Group Recent Development
    Table 60. Mylan Company Details
    Table 61. Mylan Business Overview
    Table 62. Mylan Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product
    Table 63. Mylan Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022) & (US$ Million)
    Table 64. Mylan Recent Development
    Table 65. Aurobindo Pharma Company Details
    Table 66. Aurobindo Pharma Business Overview
    Table 67. Aurobindo Pharma Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product
    Table 68. Aurobindo Pharma Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022) & (US$ Million)
    Table 69. Aurobindo Pharma Recent Development
    Table 70. Dr. Reddy's Laboratories Company Details
    Table 71. Dr. Reddy's Laboratories Business Overview
    Table 72. Dr. Reddy's Laboratories Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product
    Table 73. Dr. Reddy's Laboratories Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022) & (US$ Million)
    Table 74. Dr. Reddy's Laboratories Recent Development
    Table 75. Actavis Company Details
    Table 76. Actavis Business Overview
    Table 77. Actavis Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product
    Table 78. Actavis Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022) & (US$ Million)
    Table 79. Actavis Recent Development
    Table 80. Wuxi Apptec Company Details
    Table 81. Wuxi Apptec Business Overview
    Table 82. Wuxi Apptec Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product
    Table 83. Wuxi Apptec Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022) & (US$ Million)
    Table 84. Wuxi Apptec Recent Development
    Table 85. Zhejiang NHU Company Details
    Table 86. Zhejiang NHU Business Overview
    Table 87. Zhejiang NHU Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product
    Table 88. Zhejiang NHU Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022) & (US$ Million)
    Table 89. Zhejiang NHU Recent Development
    Table 90. Research Programs/Design for This Report
    Table 91. Key Data Information from Secondary Sources
    Table 92. Key Data Information from Primary Sources
List of Figures
    Figure 1. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Picture
    Figure 2. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size 2017-2028 (US$ Million)
    Figure 4. United States Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 5. United States Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size 2017-2028 (US$ Million)
    Figure 6. United States Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share in Global 2017-2028
    Figure 7. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Report Years Considered
    Figure 8. Product Picture of Paracetamol
    Figure 9. Product Picture of Ibuprofen
    Figure 10. Product Picture of Aspirin
    Figure 11. Product Picture of Naproxen
    Figure 12. Product Picture of Others
    Figure 13. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Type in 2022 & 2028
    Figure 14. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2017-2028) & (US$ Million)
    Figure 15. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Type (2017-2028)
    Figure 16. United States Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Type in 2022 & 2028
    Figure 17. United States Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2017-2028) & (US$ Million)
    Figure 18. United States Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Type (2017-2028)
    Figure 19. Product Picture of Hospital Pharmacies
    Figure 20. Product Picture of Retail Pharmacies
    Figure 21. Product Picture of Online Pharmacies
    Figure 22. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Application in 2022 & 2028
    Figure 23. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2017-2028) & (US$ Million)
    Figure 24. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Application (2017-2028)
    Figure 25. United States Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Application in 2022 & 2028
    Figure 26. United States Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2017-2028) & (US$ Million)
    Figure 27. United States Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Application (2017-2028)
    Figure 28. North America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 29. U.S. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 30. Canada Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 31. Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 32. Germany Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 33. France Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 34. U.K. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 35. Italy Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 36. Russia Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 37. Asia-Pacific Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 38. China Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 39. Japan Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 40. South Korea Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 41. India Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 42. Australia Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Taiwan Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Indonesia Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Thailand Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Malaysia Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Philippines Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Latin America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 49. Mexico Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Brazil Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Argentina Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Middle East & Africa Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 53. Turkey Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 54. Saudi Arabia Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 55. UAE Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 56. Novartis Revenue Growth Rate in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022)
    Figure 57. Pfizer Revenue Growth Rate in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022)
    Figure 58. Boehringer Ingelheim Revenue Growth Rate in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022)
    Figure 59. Teva Pharmaceutical Revenue Growth Rate in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022)
    Figure 60. Hospira Revenue Growth Rate in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022)
    Figure 61. Lonza Group Revenue Growth Rate in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022)
    Figure 62. Mylan Revenue Growth Rate in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022)
    Figure 63. Aurobindo Pharma Revenue Growth Rate in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022)
    Figure 64. Dr. Reddy's Laboratories Revenue Growth Rate in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022)
    Figure 65. Actavis Revenue Growth Rate in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022)
    Figure 66. Wuxi Apptec Revenue Growth Rate in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022)
    Figure 67. Zhejiang NHU Revenue Growth Rate in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022)
    Figure 68. Bottom-up and Top-down Approaches for This Report
    Figure 69. Data Triangulation
    Figure 70. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Novartis
Pfizer
Boehringer Ingelheim
Teva Pharmaceutical
Hospira
Lonza Group
Mylan
Aurobindo Pharma
Dr. Reddy's Laboratories
Actavis
Wuxi Apptec
Zhejiang NHU
Frequently Asked Questions
Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Nuclear Cardiology

Nuclear Cardiology market is segmented by region (country), players, by Type and by Application.  ... Read More

NMR Spectrometers

NMR Spectrometers market is segmented by region (country), players, by Type and by Application. P ... Read More